Syneos Health

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. 

We bring together a talented team of professionals, who work globally, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. 

Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment. 

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.

Accelerating Commercial Success

Blending a deep understanding of human behavior and the latest technology with our hard-earned knowledge and insights gained from supporting the commercialization of more products than any other partner, we deliver predictive solutions that reduce risk, accelerate commercial performance, and fulfill our industry’s promise to patients.

Good Science Is Not Good Enough

A comprehensive guide for pre-commercial companies looking to develop a value creation story to differentiate in a complex funding environment 

Dealmakers’ Intentions 2024

Learn more about 2024 expectations of biopharma decision-makers in this forward-looking measure of dealmaking activity 

New Opportunities for Value Creation

An overview of strategic and operational implications for the biotech C-suite looking to succeed in an increasingly competitive environment  

Partnering with Purpose

We Share Your Purpose. 
Your Goal Is Our Goal. 

A world-class organization of proactive, trusted experts, empowered with tools and technologies to deliver.

Focus on what matters to you most – getting life-changing therapies to patients.

For more information on partnership opportunities at other FT Live events, get in touch today to see how you can get involved.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice